| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Trading | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 4/May/2005 | | Canada | Alberta | |
|
|
| Exchange Filing Office |
| Location |
| Toronto Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Medical And Diagnostic Laboratories
| News Release March 25, 2015-Ventripoint has created tools to monitor patients with heart disease, a leading cause of death in developed countries. VMS(TM) is the first cost-effective and accurate tool for measuring right ventricle heart function. The Company has a suite of applications for all major heart diseases and imaging modalities including congenital heart disease, left or right heart failure and normal hearts - a multi-billion dollar market potential.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| VPT | VentriPoint Diagnostics Ltd. | TSX Venture | TRADING |
|
|
| Name History | From | To |
| VentriPoint Diagnostics Ltd. | 26/Sep/2007 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
